Related references
Note: Only part of the references are listed.Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Correcting 18F-fluoride PET static scan measurements of skeletal plasma clearance for tracer efflux from bone
Musib Siddique et al.
NUCLEAR MEDICINE COMMUNICATIONS (2014)
18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease
Michelle L. Frost et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
18F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: A prospective, randomized, controlled clinical study
Michelle L. Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Clinical utility of 18F-fluoride PET/CT in benign and malignant bone diseases
Yuxin Li et al.
BONE (2012)
Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images
Musib Siddique et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Quantitative assessment of dynamic PET imaging data in cancer imaging
Mark Muzi et al.
MAGNETIC RESONANCE IMAGING (2012)
A semipopulation input function for quantifying static and dynamic 18F-fluoride PET scans
Glen Mervyn Blake et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
M. L. Frost et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
Y. Al-beyatti et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Can PET-CT Imaging and Radiokinetic Analyses Provide Useful Clinical Information on Atypical Femoral Shaft Fracture in Osteoporotic Patients?
C. Haile Chesnut et al.
CURRENT OSTEOPOROSIS REPORTS (2012)
Quantitative PET Imaging Using 18F Sodium Fluoride in the Assessment of Metabolic Bone Diseases and the Monitoring of Their Response to Therapy
Glen M. Blake et al.
PET CLINICS (2012)
Interpretation of 41Ca data using compartmental modeling in post-menopausal women
Wang-Hee Lee et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Radionuclide studies of bone metabolism: Do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
Glen M. Blake et al.
BONE (2011)
Differential Effects of Teriparatide on Regional Bone Formation Using 18F-Fluoride Positron Emission Tomography
Michelle L. Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods
Musib Siddique et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Validation of image-derived arterial input functions at the femoral artery using 18F-fluoride positron emission tomography
Tanuj Puri et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Validation of new image-derived arterial input functions at the aorta using 18F-fluoride positron emission tomography
Tanuj Puri et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
The assessment of bone formation and bone resorption in osteoporosis: A comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kinetics
J. Reeve et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Kinetic Analysis of 18F-Fluoride PET Images of Breast Cancer Bone Metastases
Robert K. Doot et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Molecular Mechanisms of Bone 18F-NaF Deposition
Johannes Czernin et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization
G. Boivin et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: 18F-fluoride PET study of treatment-naive and treated postmenopausal women
Michelle L. Frost et al.
BONE (2009)
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
Sarah J. Glover et al.
BONE (2009)
Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States
Sarah J. Glover et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effects of Alendronate on Bone Metabolism in Glucocorticoid-Induced Osteoporosis Measured by 18F-Fluoride PET: A Prospective Study
Kenzo Uchida et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Quantitative Studies of Bone Using 99mTc-Methylene Diphosphonate Skeletal Plasma Clearance
Glen M. Blake et al.
SEMINARS IN NUCLEAR MEDICINE (2009)
Skeletal PET with F-18-fluoride: Applying new technology to an old tracer
Frederick D. Grant et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Atypical Paget's disease with quantitative assessment of tracer kinetics
Gopinath Gnanasegaran et al.
CLINICAL NUCLEAR MEDICINE (2007)
Evaluation of 41calcium as a new approach to assess changes in bone metabolism:: Effect of a bisphosphonate intervention in postmenopausal women with low bone mass
Eberhard Denk et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
Robert Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass
MR McClung et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
M Arlot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
PJ Meunier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography
ML Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure
YB Jiang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Coupling of porcine bone blood flow and metabolism in high-turnover bone disease measured by [15O]H2O and [18F]fluoride ion positron emission tomography
M Piert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study
DW Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
